Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential benefits of funding immunotherapy research for people with early-stage type 1 diabetes.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department delivers research into the diagnosis, treatment, and management of type 1 diabetes through the research infrastructure of the National Institute for Health and Care Research (NIHR), comprised of biomedical research centres (BRCs), clinical research facilities (CRFs), and its Research Delivery Network (RDN). Through this infrastructure:
The NIHR continues to welcome high-quality applications for research into type 1 diabetes, which will be assessed against its normal criteria, and judged in open competition.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment her department has made of the potential impact of funding for earlier diagnosis and specialist heart failure services on NHS expenditure associated with emergency admissions.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department plans to pilot the provision of NT-proBNP point-of-care testing in community pharmacies for people presenting with symptoms of heart failure.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department for Energy Security & Net Zero:
To ask the Secretary of State for Energy Security and Net Zero, what steps her Department is taking to support investment in net zero and renewable energy production facilities in Nottingham and Nottinghamshire.
Answered by Michael Shanks - Minister of State (Department for Energy Security and Net Zero)
Nottinghamshire is benefiting from significant clean energy investment.
The STEP programme will deliver a prototype fusion power plant at West Burton, supporting reindustrialisation around the site – a former coal power station – and supporting thousands of jobs.
HyMarnham Power, which was successful in the first hydrogen allocation round (HAR1), is transforming the former High Marnham coal-fired power station into a clean energy hub, introducing 9.3 MW of low-carbon hydrogen production capacity.
The Government has supported solar energy farms in Nottinghamshire through the Contracts for Difference scheme.
The Government is committed to ensuring that the clean energy transition benefits every community.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department for Education:
To ask the Secretary of State for Education, what steps the Department is taking to ensure that careers advisers receive training on the challenges experienced by young people with dyslexia and other neurodiverse differences.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
Careers adviser qualifications and continuing professional development (CPD) include content on special educational needs and disabilities (SEND). This helps advisers understand dyslexia and other forms of neurodiversity, identify barriers to learning and progression, work effectively with special educational needs coordinators and other professionals, and provide tailored careers guidance.
To further strengthen support for young people with SEND, the department has commissioned Transform Your Training to develop a series of CPD modules for careers advisers, including a module focused specifically on supporting young people with SEND.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what estimate the department has made of the number and proportion of young people who are not in education, employment or training who have dyslexia.
Answered by Lilian Greenwood - Parliamentary Under-Secretary (Department for Work and Pensions)
The independent Office for National Statistics estimate that there are 981,000 16-24 year-olds not in education, employment and training, down 30,000 (0.5% points) on the quarter. The DWP does not hold data on what proportion of young people not in education, employment or training have dyslexia.
With around one million young people not in education, employment and training, this Government will not leave an entire generation of young people behind.
The Government is investing an additional £2.5 billion by 2029 into the Youth Guarantee and the Growth and Skills Levy. This investment will support almost one million young people and create up to 500,000 opportunities to earn and learn, including through expanded network of Youth Hubs, earlier intensive support in Jobs Centres through a new Youth Guarantee Gateway, additional work experience and training opportunities, a £3,000 Youth Jobs Grant and £2,000 apprenticeship hiring payment for employers, and a fully funded six month job for long-term unemployed 18–24-year-olds.
We also recognise the crisis of participation that Alan Milburn has so clearly laid out in his interim report. We will use this interim report to continue to build our reforms and look forward to final recommendations in the Autumn.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve dementia diagnosis, treatment and long-term care provision for military veterans in (i) Broxtowe constituency and (ii) Nottinghamshire.
Answered by Alison McGovern - Minister of State (Department of Health and Social Care)
The Government is proud of the courage and dedication of our Armed Forces. It is our duty to ensure that those that have been injured whilst serving in the Armed Forces, whether physically or mentally, receive the very best possible care.
Local integrated care boards commission dementia healthcare services and are expected to deliver services based on local population needs, taking account of National Institute for Health and Care Excellence guidelines.
We will publish the first ever Modern Service Framework for Frailty and Dementia to set a clear direction and a long-term blueprint to improve outcomes for people with dementia. It will seek to reduce unwarranted variation and narrow inequality for those living with dementia.
We are engaging with a wide group of partners to understand what should be included to ensure the best outcomes for people living with frailty and dementia.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of support available to people with (a) multiple sclerosis and (b) other progressive neurological conditions in (i) Broxtowe constituency, (ii) Nottinghamshire and (iii) England.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions, including in Broxtowe and Nottinghamshire. NHS England has published a service specification for specialised neurology services, which aims to ensure that patients receive coordinated, multidisciplinary care and timely access to appropriate treatments.
The National Institute for Health and Care Excellence has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically and cost‑effective treatments based on the best available evidence. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.
In addition, programmes such as Getting It Right First Time are helping to improve outcomes and reduce variation in neurological care across the country. NHS RightCare’s progressive neurological conditions toolkit supports improved outcomes for people with MS by helping local systems identify and address unwarranted variation in care, and by setting out evidence‑based pathways for timely diagnosis, treatment, and ongoing management. The toolkit promotes a coordinated, multidisciplinary approach and emphasises proactive management of symptoms and complications.
The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.
Integrated care boards are responsible for commissioning services to meet the needs of their local populations and are expected to have regard to National Institute for Health and Care Excellence and other guidance to ensure patients can access high‑quality care and treatment.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase capacity within NHS neurology services in (i) Broxtowe, (ii) Nottinghamshire, and (iii) England.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions, including in Broxtowe and Nottinghamshire. NHS England has published a service specification for specialised neurology services, which aims to ensure that patients receive coordinated, multidisciplinary care and timely access to appropriate treatments.
The National Institute for Health and Care Excellence has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically and cost‑effective treatments based on the best available evidence. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.
In addition, programmes such as Getting It Right First Time are helping to improve outcomes and reduce variation in neurological care across the country. NHS RightCare’s progressive neurological conditions toolkit supports improved outcomes for people with MS by helping local systems identify and address unwarranted variation in care, and by setting out evidence‑based pathways for timely diagnosis, treatment, and ongoing management. The toolkit promotes a coordinated, multidisciplinary approach and emphasises proactive management of symptoms and complications.
The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.
Integrated care boards are responsible for commissioning services to meet the needs of their local populations and are expected to have regard to National Institute for Health and Care Excellence and other guidance to ensure patients can access high‑quality care and treatment.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what support her Department is providing to Integrated Care Systems to ensure people with multiple sclerosis receive the best possible care.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions, including in Broxtowe and Nottinghamshire. NHS England has published a service specification for specialised neurology services, which aims to ensure that patients receive coordinated, multidisciplinary care and timely access to appropriate treatments.
The National Institute for Health and Care Excellence has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically and cost‑effective treatments based on the best available evidence. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.
In addition, programmes such as Getting It Right First Time are helping to improve outcomes and reduce variation in neurological care across the country. NHS RightCare’s progressive neurological conditions toolkit supports improved outcomes for people with MS by helping local systems identify and address unwarranted variation in care, and by setting out evidence‑based pathways for timely diagnosis, treatment, and ongoing management. The toolkit promotes a coordinated, multidisciplinary approach and emphasises proactive management of symptoms and complications.
The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.
Integrated care boards are responsible for commissioning services to meet the needs of their local populations and are expected to have regard to National Institute for Health and Care Excellence and other guidance to ensure patients can access high‑quality care and treatment.